Abstract
Vasculogenesis is essential for embryonic development. The vasculature and the intravascular blood compartment develop in a close spatial and temporal relationship. Here we discuss how thrombin, as the common final effector of the blood coagulation system, helps to coordinate vasculogenesis. Mouse models lacking coagulation factors result in impaired thrombin generation and display a phenotype of disturbed vasculogenesis. Notably, either impaired thrombin binding to its cellular receptor PAR1 or disrupted downstream signaling via G-proteins results in very similar phenotypes in mouse models. Given that vasculogenesis in adults follows comparable signaling patterns as vasculogenesis in embryos, understanding these pathways allows the possibility of identifying potential therapeutic targets for the use in the treatment of cardiovascular disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bi,L., Lawler,A. M.,Antonarakis,S. E.,High,K. A.,Gearhart,J. D., and Kazazian,H. H.,Jr. 1995.Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat. Genet. 10: 119–21.
Bugge,T. H.,Xiao,Q., Kombrinck,K. W.,Flick,M. J.,Holmback,K., Danton,M. J.,Colbert,M. C.,Witte,D. P.,Fujikawa,K., Davie,E. W., and Degen,J. L. 1996. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc. Natl. Acad. Sci. USA 93: 6258–63.
Camerer,E., Huang,W., and Coughlin,S. R. 2000. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. USA 97: 5255–60.
Carmeliet,P., Mackman,N., Moons,L., Luther,T., Gressens,P., Van Vlaenderen,I., Demunck,H., Kasper,M., Breier,G., Evrard,P., Muller,M., Risau,W., Edgington,T., and Collen,D. 1996. Role of tissue factor in embryonic blood vessel development. Nature 383: 73–5.
Connolly,A. J.,Ishihara,H., Kahn,M. L.,Farese, and R. V.,Jr.,Coughlin,S. R. 1996. Role of the thrombin receptor in development and evidence for a second receptor. Nature 381: 516–19.
Cui,J., O’Shea,K. S.,Purkayastha,A., Saunders,T. L., and Ginsburg,D. 1996. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 384: 66–8.
Darrow,A. L.,Fung-Leung,W. P.,Ye,R. D.,Santulli,R. J.,Cheung,W. M.,Derian,C. K.,Burns,C. L.,Damiano,B. P.,Zhou,L., Keenan,C. M.,Peterson,P. A., and Andrade-Gordon,P. 1996. Biological consequences of thrombin receptor deficiency in mice. Thromb. Haemost. 76: 860–6.
Dewerchin,M., Liang,Z., Moons,L., Carmeliet,P., Castellino,F. J.,Collen,D., and Rosen,E. D. 2000. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb. Haemost. 83: 185–90.
Dumont,D. J.,Gradwohl,G., Fong,G. H.,Puri,M. C.,Gertsenstein,M., Auerbach,A., and Breitman,M. L.1994.Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8: 1897–909.
Esmon,C. T. 1987. The regulation of natural anticoagulant pathways. Science 235: 1348–52.
Fuentes-Prior,P., Iwanaga,Y., Huber,R., Pagila,R., Rumennik,G., Seto,M., Morser,J., Light,D. R., and Bode,W. 2000. Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex. Nature 404: 518–25.
Griffin,C. T.,Srinivasan,Y., Zheng,Y. W.,Huang,W., and Coughlin,S. R. 2001. A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 293: 1666–70.
Healy,A. M.,Rayburn,H. B.,Rosenberg,R. D., and Weiler,H. 1995. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc. Natl. Acad. Sci. USA 92: 850–4.
Isermann,B., Hendrickson,S. B.,Hutley,K., Wing,M., and Weiler,H. 2001. Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development 128: 827–38.
Lin,H.-F.,Maeda,N., Smithies,O., Straight,D. L., and Stafford,D. W. 1997. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 90: 3962–6.
Offermanns,S., Mancino,V., Revel,J. P., and Simon,M. I. 1997. Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 275: 533–6.
Parry,G. C., and Mackman,N. 2000. Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain. J. Clin. Invest. 105: 1547–54.
Riewald,M., Kravchenko,V. V.,Petrovan,R. J.,O’Brien,P. J.,Brass,L. F.,Ulevitch,R. J., and Ruf,W. 2001. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 97: 3109–16.
Riewald,M., Petrovan,R. J.,Donner,A., Mueller,B. M., and Ruf,W. 2002. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296: 1880–2.
Rosen,E. D.,Chan,J. C.,Idusogie,E., Clotman,F., Vlasuk,G., Luther,T., Jalbert,L. R.,Albrecht,S., Zhong,L., Lissens,A., Schoonjans,L., Moons,L., Collen,D., Castellino,F. J., and Carmeliet,P. 1997. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 390: 290–4.
Ruppel,K. M.,Willison,D., Kataoka,H., Wang,A., Zheng,Y.-W.,Cornelissen,I., Yin,L., Xu,S. M., and Coughlin,S. R. 2005. Essential role for Gα13. in endothelial cells during embryonic development Proc. Natl. Acad. Sci. USA 102: 8281–6.
Shivdasani,R. A.,Rosenblatt,M. F.,Zucker-Franklin,D., Jackson,C. W.,Hunt,P., Saris,C. J., and Orkin,S. H. 1995. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81: 695–704.
Suh,T. T.,Holmback,K., Jensen,N. J.,Daugherty,C. C.,Small,K., Simon,D. I.,Potter,S., and Degen,J. L. 1995. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9: 2020–33.
Sun,W. Y.,Witte,D. P.,Degen,J. L.,Colbert,M. C.,Burkart,M. C.,Holmback,K., Xiao,Q., Bugge,T. H., and Degen,S. J. 1998. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc. Natl. Acad. Sci. USA 95: 7597–602.
Tai,S. J.,Herzog,R. W.,Margaritis,P., Arruda,V. R.,Chu,K., Golden,J. A.,Labosky,P. A., and High,K. A. 2008. A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X. J. Thromb. Haemost. 6: 339–45.
Toomey,J. R.,Kratzer,K. E.,Lasky,N. M.,Stanton,J. J., and Broze,G. J.,Jr. 1996.Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88: 1583–7.
Xue,J., Wu,Q., Westfield,L. A.,Tuley,E. A.,Lu,D., Zhang,Q., Shim,K., Zheng,X., and Sadler,J. E. 1998. Incomplete embryonic lethality and fatal neonatal haemorrhage caused by prothrombin deficiency in mice. Proc. Natl. Acad. Sci. USA 95: 7603–7.
Yang,L., Bae,J.-S.,Manithody,C., and Rezaie,A. R. 2007. Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1. J. Biol. Chem. 282: 25493–500.
Yang,T. L.,Cui,J., Taylor,J. M.,Yang,A., Gruber,S. B., and Ginsburg,D. 2000. Rescue of fatal neonatal haemorrhage in factor V deficient mice by low level transgene expression. Thromb. Haemost. 83: 70–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Moser, M., Patterson*, C. (2009). The Role of Thrombin in Vascular Development. In: Maragoudakis, M., Tsopanoglou, N. (eds) Thrombin. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09637-7_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-09637-7_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-09636-0
Online ISBN: 978-0-387-09637-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)